In previous studies, researchers have demonstrated that activation of the EGFR pathway induced PD-L1 expression [2, 16, 18], and found PD-L1 was significantly higher in patients with the following characteristics: women, never smokers and with adenocarcinoma [2, 16]. Here, CD274 is linked to adenocarcinoma.